Similar articles

• [Membrane cofactor protein (MCP, CD46)].

  Seya T. Seya T. Nihon Rinsho. 2010 Jun;68 Suppl 6:98-101. Nihon Rinsho. 2010. PMID: 20942011 Japanese. No abstract available.
• [Immunological tests: Decay-accelerating factor].

  Negoro T, Tobe T. Negoro T, et al. Nihon Rinsho. 2005 Jul;63 Suppl 7:98-100. Nihon Rinsho. 2005. PMID: 16111199 Review. Japanese. No abstract available.
• [Membrane cofactor protein (MCP, CD46)].

  Seya T, Taniguchi M, Matsumoto M. Seya T, et al. Nihon Rinsho. 1999 Nov;57 Suppl:75-8. Nihon Rinsho. 1999. PMID: 10635779 Review. Japanese. No abstract available.
• Protection of mammalian cells from complement-mediated lysis by transfection of human membrane cofactor protein and decay-accelerating factor.

  Oglesby TJ, White D, Tedja I, Liszewski K, Wright L, Van den Bogarde J, Atkinson JP. Oglesby TJ, et al. Trans Assoc Am Physicians. 1991;104:164-72. Trans Assoc Am Physicians. 1991. PMID: 1726964 No abstract available.
• Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome.

  Richards A, Kemp EJ, Liszewski MK, Goodship JA, Lampe AK, Decorte R, Müslümanoğlu MH, Kavukcu S, Filler G, Pirson Y, Wen LS, Atkinson JP, Goodship TH. Richards A, et al. Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12966-71. doi: 10.1073/pnas.2135497100. Epub 2003 Oct 17. Proc Natl Acad Sci U S A. 2003. PMID: 14566051 Free PMC article.